INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 5 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,332 | -22.5% | 137 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $5,587 | +9.4% | 137 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $5,106 | +6.8% | 137 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $4,780 | -40.2% | 137 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $8,000 | +14.3% | 137 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $7,000 | -30.0% | 137 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $10,000 | -37.5% | 137 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $16,000 | -11.1% | 137 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $18,000 | -18.2% | 137 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $22,000 | +100.0% | 137 | 0.0% | 0.01% | +66.7% |
| Q1 2021 | $11,000 | +57.1% | 137 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $7,000 | +133.3% | 137 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $3,000 | 0.0% | 137 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $3,000 | +50.0% | 137 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | 0.0% | 137 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 137 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 137 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 137 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 137 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $2,000 | -50.0% | 137 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $4,000 | 0.0% | 137 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $4,000 | – | 137 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |